Drug Profile
Research programme: P2Y receptor antagonists - Astellas
Alternative Names: AS 1645; AS 1710721-00Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Astellas Pharma
- Class Quinolones
- Mechanism of Action P2Y receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- Available For Licensing Yes
Highest Development Phases
- No development reported Thrombosis
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Thrombosis in Japan (IV)
- 16 Jul 2016 No recent reports of development identified for preclinical development in Thrombosis in Japan (PO)
- 20 Aug 2009 Preclinical trials in Thrombosis in Japan (IV)